IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
143.91
-4.53 (-3.05%)
Apr 17, 2025, 4:00 PM EDT - Market closed
IQVIA Holdings Revenue
In the year 2024, IQVIA Holdings had annual revenue of $15.41B with 2.81% growth. IQVIA Holdings had revenue of $3.96B in the quarter ending December 31, 2024, with 2.33% growth.
Revenue (ttm)
$15.41B
Revenue Growth
+2.81%
P/S Ratio
1.69
Revenue / Employee
$175,057
Employees
88,000
Market Cap
25.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
IQV News
- 3 days ago - Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report - Business Wire
- 5 weeks ago - IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services - Business Wire
- 6 weeks ago - IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials - Business Wire
- 7 weeks ago - Global Healthy Living Foundation and IQVIA Institute Report Millions of Adult Vaccines Likely Missed When States Restrict Pharmacist Participation - Business Wire
- 7 weeks ago - IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence - Business Wire
- 2 months ago - IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025 - Business Wire
- 2 months ago - IQVIA Releases 2024 Sustainability Report - Business Wire
- 2 months ago - IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way - Seeking Alpha